Novavax’s protein-based COVID-19 vaccine, Nuvaxovid, wins FDA approval for older adults and people with underlying health risks under …
Novavax’s protein-based COVID-19 vaccine, Nuvaxovid, wins FDA approval for older adults and people with underlying health risks under …
Phase III SEQUOIA-HCM analyses show aficamten offers benefit to patients with varying symptom severity and across regions, opening …
Researchers propose a new framework that combines domestic real-world data with overseas trial data to make global clinical …
In May 2025, a gene therapy for Rett syndrome has cleared major regulatory design review and is activating …
New oral vaccine succeeds against multiple cholera strains offering promise for broad use in endemic regions
New antibody therapeutic enters Phase 1 with hopes of helping women with hot flashes and night sweats
Regulatory nod gives push to a potentially powerful combination in acute myeloid leukaemia
A new antibody-drug conjugate brings hope for patients with lung cancer who have few options
Mid-stage results show meaningful reductions in pathological protein, setting stage for later-phase trials
Combination therapy delivers promising efficacy and manageable safety in PD-1 refractory head and neck squamous cell carcinoma
